Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’

The present letter to editor is related to Bohra A et al Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World J Gastroenterol 2020; 26(18): 2221-2231. Hepatic encephalopathy (HE) is a significant and frequent major decompensating...

Descripción completa

Detalles Bibliográficos
Autores principales: Elzubeir, Amera, Alam, Syed Munawer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701945/
https://www.ncbi.nlm.nih.gov/pubmed/33311952
http://dx.doi.org/10.3748/wjg.v26.i44.7085
_version_ 1783616515894935552
author Elzubeir, Amera
Alam, Syed Munawer
author_facet Elzubeir, Amera
Alam, Syed Munawer
author_sort Elzubeir, Amera
collection PubMed
description The present letter to editor is related to Bohra A et al Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World J Gastroenterol 2020; 26(18): 2221-2231. Hepatic encephalopathy (HE) is a significant and frequent major decompensating event in cirrhosis. However clinical studies examining the clinical outcome of HE are lacking despite its high prevalence.
format Online
Article
Text
id pubmed-7701945
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-77019452020-12-10 Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’ Elzubeir, Amera Alam, Syed Munawer World J Gastroenterol Letter to the Editor The present letter to editor is related to Bohra A et al Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World J Gastroenterol 2020; 26(18): 2221-2231. Hepatic encephalopathy (HE) is a significant and frequent major decompensating event in cirrhosis. However clinical studies examining the clinical outcome of HE are lacking despite its high prevalence. Baishideng Publishing Group Inc 2020-11-28 2020-11-28 /pmc/articles/PMC7701945/ /pubmed/33311952 http://dx.doi.org/10.3748/wjg.v26.i44.7085 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Letter to the Editor
Elzubeir, Amera
Alam, Syed Munawer
Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’
title Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’
title_full Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’
title_fullStr Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’
title_full_unstemmed Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’
title_short Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’
title_sort letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with rifaxamin’
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701945/
https://www.ncbi.nlm.nih.gov/pubmed/33311952
http://dx.doi.org/10.3748/wjg.v26.i44.7085
work_keys_str_mv AT elzubeiramera lettertoeditorprognosticsignificanceofhepaticencephalopathyinpatientswithcirrhosistreatedwithrifaxamin
AT alamsyedmunawer lettertoeditorprognosticsignificanceofhepaticencephalopathyinpatientswithcirrhosistreatedwithrifaxamin

Ejemplares similares